BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23394728)

  • 1. Quantifying loss of CD34+ cells collected by apheresis after processing for freezing and post-thaw.
    Castelhano MV; Reis-Alves SC; Vigorito AC; Rocha FF; Pereira-Cunha FG; De Souza CA; Lorand-Metze I
    Transfus Apher Sci; 2013 Apr; 48(2):241-6. PubMed ID: 23394728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg.
    Abrahamsen JF; Wentzel-Larsen T; Bruserud O
    Cytotherapy; 2004; 6(4):356-62. PubMed ID: 16146888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.
    Lane TA; Bashey A; Carrier E; Holman P; Castro J; Mullen M; Ward DM; Ada O; Ball ED
    Cytotherapy; 2004; 6(4):318-27. PubMed ID: 16146884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.
    Berens C; Heine A; Müller J; Held SA; Mayer K; Brossart P; Oldenburg J; Pötzsch B; Wolf D; Rühl H
    Cytotherapy; 2016 Oct; 18(10):1325-31. PubMed ID: 27491794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukapheresis cell concentration adjustment required for a successful recovery of HSC after cryopreservation.
    Mohammed RN; Ahmad D; Khoshnaw N; Hassan DO; Abdulrahman HA; Vacca M; Possenti M; Faruq D; Omer H; Muhamad S; Majolino I; Othman DN
    Cryobiology; 2020 Feb; 92():21-25. PubMed ID: 31563591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
    Hicks C; Isaacs A; Wong R; Chong BH
    Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loss of CD34+ cells in peripheral hematopoietic stem cell products cryopreserved by non-controlled rate freezing and stored at -80 °C after overnight storage.
    Donmez A; Yilmaz F; Soyer N; Cagirgan S; Arik B; Tombuloglu M
    Transfus Apher Sci; 2014 Oct; 51(2):188-92. PubMed ID: 25217992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products.
    Sartor M; Antonenas V; Garvin F; Webb M; Bradstock KF
    Bone Marrow Transplant; 2005 Aug; 36(3):199-204. PubMed ID: 15937512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use.
    Bohbot A; Lioure B; Faradji A; Schmitt M; Cuillerot JM; Laplace A; Oberling F
    Bone Marrow Transplant; 1996 Feb; 17(2):259-64. PubMed ID: 8640176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric CD34+ determination in stem cell transplantation: before or after cryopreservation of grafts?
    Fietz T; Reufi B; Mücke C; Thiel E; Knauf WU
    J Hematother Stem Cell Res; 2002 Apr; 11(2):429-35. PubMed ID: 11983115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
    Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
    J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheres.
    Koizumi K; Nishio M; Endo T; Takashima H; Haseyama Y; Fujimoto K; Yamamoto S; Sato N; Ikebuchi K; Ikeda H; Koike T; Sawada K
    Bone Marrow Transplant; 2000 Oct; 26(7):787-93. PubMed ID: 11042662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
    Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation.
    Ferrero D; Tarella C; Cherasco C; Bondesan P; Omedè P; Ravaglia R; Caracciolo D; Castellino C; Pileri A
    Bone Marrow Transplant; 1998 Feb; 21(4):409-13. PubMed ID: 9509977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.
    Abrahamsen JF; Stamnesfet S; Liseth K; Hervig T; Bruserud O
    Transfusion; 2005 Feb; 45(2):248-53. PubMed ID: 15660835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.